Teesalu T - Search Results

1

Editorial on Special Issue "Precision Delivery of Drugs and Imaging Agents with Peptides".

Kurrikoff K, Teesalu T. Kurrikoff K, et al. Among authors: teesalu t. Pharmaceutics. 2022 Feb 23;14(3):486. doi: 10.3390/pharmaceutics14030486. Pharmaceutics. 2022. PMID: 35335863 Free PMC article.

2

Targeting Pro-Tumoral Macrophages in Early Primary and Metastatic Breast Tumors with the CD206-Binding mUNO Peptide.

Lepland A, Asciutto EK, Malfanti A, Simón-Gracia L, Sidorenko V, Vicent MJ, Teesalu T, Scodeller P. Lepland A, et al. Among authors: teesalu t. Mol Pharm. 2020 Jul 6;17(7):2518-2531. doi: 10.1021/acs.molpharmaceut.0c00226. Epub 2020 Jun 1. Mol Pharm. 2020. PMID: 32421341

3

Cationic Liposomes as Vectors for Nucleic Acid and Hydrophobic Drug Therapeutics.

Ewert KK, Scodeller P, Simón-Gracia L, Steffes VM, Wonder EA, Teesalu T, Safinya CR. Ewert KK, et al. Among authors: teesalu t. Pharmaceutics. 2021 Aug 30;13(9):1365. doi: 10.3390/pharmaceutics13091365. Pharmaceutics. 2021. PMID: 34575441 Free PMC article. Review.

4

Bi-Functional Peptides as a New Therapeutic Tool for Hepatocellular Carcinoma.

Savier E, Simon-Gracia L, Charlotte F, Tuffery P, Teesalu T, Scatton O, Rebollo A. Savier E, et al. Among authors: teesalu t. Pharmaceutics. 2021 Oct 6;13(10):1631. doi: 10.3390/pharmaceutics13101631. Pharmaceutics. 2021. PMID: 34683924 Free PMC article.

5

Targeted Delivery of Epidermal Growth Factor to the Human Placenta to Treat Fetal Growth Restriction.

Renshall LJ, Beards F, Evangelinos A, Greenwood SL, Brownbill P, Stevens A, Sibley CP, Aplin JD, Johnstone ED, Teesalu T, Harris LK. Renshall LJ, et al. Among authors: teesalu t. Pharmaceutics. 2021 Oct 25;13(11):1778. doi: 10.3390/pharmaceutics13111778. Pharmaceutics. 2021. PMID: 34834193 Free PMC article.

6

PL1 Peptide Engages Acidic Surfaces on Tumor-Associated Fibronectin and Tenascin Isoforms to Trigger Cellular Uptake.

Lingasamy P, Põšnograjeva K, Kopanchuk S, Tobi A, Rinken A, General IJ, Asciutto EK, Teesalu T. Lingasamy P, et al. Among authors: teesalu t. Pharmaceutics. 2021 Nov 24;13(12):1998. doi: 10.3390/pharmaceutics13121998. Pharmaceutics. 2021. PMID: 34959279 Free PMC article.

7

Preclinical Validation of Tumor-Penetrating and Interfering Peptides against Chronic Lymphocytic Leukemia.

Simón-Gracia L, Loisel S, Sidorenko V, Scodeller P, Parizot C, Savier E, Haute T, Teesalu T, Rebollo A. Simón-Gracia L, et al. Among authors: teesalu t. Mol Pharm. 2022 Mar 7;19(3):895-903. doi: 10.1021/acs.molpharmaceut.1c00837. Epub 2022 Feb 3. Mol Pharm. 2022. PMID: 35113575 Free article.

8

Tumor-penetrating peptides.

Teesalu T, Sugahara KN, Ruoslahti E. Teesalu T, et al. Front Oncol. 2013 Aug 27;3:216. doi: 10.3389/fonc.2013.00216. eCollection 2013. Front Oncol. 2013. PMID: 23986882 Free PMC article.

9

New p32/gC1qR Ligands for Targeted Tumor Drug Delivery.

Paasonen L, Sharma S, Braun GB, Kotamraju VR, Chung TD, She ZG, Sugahara KN, Yliperttula M, Wu B, Pellecchia M, Ruoslahti E, Teesalu T. Paasonen L, et al. Among authors: teesalu t. Chembiochem. 2016 Apr 1;17(7):570-5. doi: 10.1002/cbic.201500564. Epub 2016 Feb 19. Chembiochem. 2016. PMID: 26895508 Free PMC article.

10

Tumor-homing peptides as tools for targeted delivery of payloads to the placenta.

King A, Ndifon C, Lui S, Widdows K, Kotamraju VR, Agemy L, Teesalu T, Glazier JD, Cellesi F, Tirelli N, Aplin JD, Ruoslahti E, Harris LK. King A, et al. Among authors: teesalu t. Sci Adv. 2016 May 6;2(5):e1600349. doi: 10.1126/sciadv.1600349. eCollection 2016 May. Sci Adv. 2016. PMID: 27386551 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page